Tristel PLC (TSTL.L) Research

Tristel plc is a company specializing in the creation, production, and global distribution of products designed to prevent infections, serving both its home market in the UK and international clients. Its operations are structured around three core divisions: the decontamination of medical devices within hospital environments, the disinfection of hospital-based environmental surfaces, and an additional 'Other' category. The firm offers an extensive range of disinfection solutions for medical instruments under its Tristel brand. These solutions are applied across a wide spectrum of clinical areas, including airway management, cardiology, ear, nose and throat (ENT), endoscopy, gastrointestinal physiology, laboratory applications, ophthalmology, phlebotomy, reproductive health/IVF, general surface disinfection, ultrasound, urology, and women's health, alongside other specialized products. Tristel plc was established in 1993 and has its main office situated in Snailwell, United Kingdom.

Market snapshot

Symbol
TSTL.L
Price
$387.5
Day change
0.00%
Market cap
$186.0M
P/E ratio
23.51x
52-week range
350-445
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Next earnings
in 4 months

Peer companies

  • 4basebio PLC (4BB.L)
  • Animalcare Group plc (ANCR.L)
  • BATM Advanced Communications Ltd. (BVC.L)
  • Bioventix PLC (BVXP.L)
  • Beximco Pharmaceuticals Limited (BXP.L)
  • Diaceutics PLC (DXRX.L)
  • EKF Diagnostics Holdings plc (EKF.L)
  • Faron Pharmaceuticals Oy (FARN.L)

Open Tristel PLC (TSTL.L) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.